Femasys is trading at $2.83 (-5.03%) amid broader market weakness on September 8, 2026.
- The Dow Jones is down 1.24%, the S&P 500 is down 0.49%, and the Nasdaq is down 0.38%.
- No new company-specific announcement was identified; Femasys’s latest listed release was the August 26 UNC Health partnership.
- A September 3 resale registration for 28.12 million shares may add dilution concerns, but its direct connection to today’s move is unconfirmed.